FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
PO:32:187 | AI-assisted reading outperforms visual scoring of pulmonary CT scans to predict interstitial lung disease progression in systemic sclerosis Francesca Motta1, Antonio Tonutti1, Federica Catapano2, Gianluca Sellaro2, Francesco Amati3, Anna Stainer3, Calogero Messana2, Stefano Erba1, Stefano Aliberti3, Marco Francone2, Carlo Selmi1, Maria De Santis1 | 1Humanitas University and IRCCS Humanitas Research Hospital, Department of Rheumatology and Clinical Immunology Rozzano, Milan, Italy; 2IRCCS Humanitas Research Hospital, Department of Radiology Rozzano, Milan, Italy; 3IRCCS Humanitas Research Hospital, Respiratory Unit Rozzano, Milan, Italy
51 -
CO:03:1 | Distinct breath metabolomic signature in systemic sclerosis patients with pulmonary arterial hypertension Martina Iacubino1, Lorenzo Rocco1, Marco Vicenzi2|3, Chiara Bellocchi2|4, Marta Mozzo4, Adriana Severino3, Monica Caronni3, Alessandro Santaniello3, Gaia Montanelli3, Barbara Vigone3, Liam Grimmett5, Matthew Kerr5, Lorenzo Beretta3. | 1Scuola di specializzazione in Allergologia e Immunologia clinica, Università degli Studi di Milano; 2Dipartimento di Scienze Cliniche e Salute di Comunità, Dipartimento di Eccellenza 2023-2027, Università degli Studi di Milano; 3Dipartimento di Malattie Cardio-Toraciche-Vascolari, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano; 4Dipartimento di Immunologia Clinica e Medicina Interna, Scleroderma Unit - Fondazione IRCCS Ca' Granda Ospedale Maggiore, Milano, Italy; 5Owlstone Medical, Cambridge, UK
273 -
PO:31:173 | Methotrexate monotherapy in early systemic sclerosis: a real-life monocentric Italian experience Claudia Iannone1|2, Ilaria Magi1|2, Antonina Minniti2, Giuseppe Armentaro2, Silvia Cavalli1|2, Manuel Sette1|2, Laura Giudice1|2, Maria Rosa Pellico1|2, Cristina Bochicchio1|2, Roberto Felice Caporali1|2, Nicoletta Del Papa1|2. | 1Dipartimento di Scienze Cliniche e di Comunità, Università degli Studi di Milano, Milano, Italy; 2Dipartimento di Reumatologia e Scienze Mediche, ASST G. Pini-CTO, Milano, Italy.
192 -
PO:20:006 | Efficacy of denosumab in glucocorticoid-induced osteoporosis patients with prior exposure to intravenous aminobisphosphonates Kiren Khalid1, Alessandro Giollo1, Mariangela Salvato1, Francesca Frizzera1, Lorenzo Di Luozzo1, Bernd Raffeiner2, Andrea Doria1 | 1Rheumatology Unit, Department of Medicine - DIMED, University of Padova, Padova, Italy; 2Department of Rheumatology, Bolzano Central Hospital, Bolzano, Italy
49 -
PO:19:283 | Hospitalization profile and complications in patients with adult-onset Still’s disease: results from a retrospective study of 74 cases Chiara Calabrese1, Alessandro Tomelleri1|2, Corrado Campochiaro1|2, Nicola Farina2, Elena Baldissera2, Marco Matucci-Cerinic1|2, Lorenzo Dagna1|2 | 1Libera Università Vita-Salute San Raffaele, Milano; 2Unità di Immunologia, Allergologia e malattie rare, IRCCS San Raffaele, Milano, Italy
186 -
PO:21:026 | Identifying patient profiles to personalize care and improve quality of life in italian EGPA patients Francesca Torracca1, Roberto Padoan2, Giacomo Emmi3|4, Lara Bernardi5, Maria Rosaria Mollo5, Omar Shalby5, Fabio Tedone6, Davide Cafiero6, Eugenia Durante1 | 1APACS APS ETS - Associazione Pazienti Sindrome di Churg Strauss EGPA Arosio, Italy; 2Rheumatology Unit, Department of Medicine DIMED, University of Padua, Italy; 3Department of Medical, Surgical and Health Sciences, University of Trieste, Italy; 4Clinical Medicine Rheumatology Unit, Cattinara University Hospital, Trieste, Italy; 5GlaxoSmithKline Medical Department Verona, Italy; 6Helaglobe SRL Firenze, Italy
43 -
CO:07:4 | Clinical and psychosocial domains in fibromyalgia: a multidimensional questionnaire approach for personalized management. Results from an Italian monocentric study Eleonora Pedretti1, Francesca Regola1, Giulia Fontana1|2, Giulia Voltarel1|2, Michela Riolfo1|2, Anna Scalvini1, Ilaria Cavazzana1|2, Franco Franceschini1|2, Roberto Gorla1. | 1Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili of Brescia; 2Department of Clinical and Experimental Sciences, University of Brescia, Italy
255 -
PO:34:209 | Increased liver stiffness and fibrosis in systemic sclerosis: a single-center transient elastography cohort study. Nicola Ortalli1|2, Simone Aldo Lari1|2, Alessandra Vacca3, Erika Meleddu1|2, Alberto Civolani4, Emanuela Vargiu4, Alberto Floris1|2, Massimo Claudio Fantini4, Alberto Cauli1|2. | 1Rheumatology Unit, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy; 2Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy; 3Rheumatology Unit, Presidio Ospedaliero CTO di Iglesias Iglesias Italy; 4Gastroenterology Unit, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy.
199 -
PO:08:119 | Infusional Advantage: Rituximab’s Role in Enhancing Adherence in Multimorbid Rheumatoid Arthritis Marco Capodiferro1, Daniele Domanico1, Angelica Napoletano1, Giulia Righetti2, Patrizia Suppressa2, Vincenzo Venerito1, Giuseppe Lopalco1, Florenzo Iannone1, Fabio Cacciapaglia1|2 | 1Rheumatology Unit, Department of Precision and Regenerative Medicine and Jonian Area DiMePRe-J University of Bari, Italy; 2Department of Medicine and Surgery, Miulli General Hospital Acquaviva delle Fonti - LUM University Casamassima Bari Acquaviva delle Fonti, Bari, Italy
38 -
PO:01:015 | Evaluation of the impact of concomitant psoriasis on the clinical and therapeutic pattern of a monocentric cohort of patients affected by spondyloarthritis associated with inflammatory bowel diseases Andrea Pace1, Marcella Falconi1, Alberto Floris1|2, Leonardo Sichi1, Francesca Onnis3, Lorenzo Meli3, Raffaela Piras3, Nicola Lutzu3, Federica Olla3, Agnese Favale3, Sara Onali3, Massimo Claudio Fantini3, Matteo Piga1|2, Alberto Cauli1|2 | 1SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari; 2SC Reumatologia, AOU Cagliari; 3SC Gastroenterologia, AOU Cagliari, Italy
168 -
PO:34:211 | Gynecological health and ultrasound evaluation among fertile women affected by Systemic sclerosis: an observational study Martina Orlandi1, Sofia Gambigliani Zoccoli2, Mariagrazia Nuara1, Riccardo Cuoghi Costantini2, Amelia Spinella1, Marco De Pinto1, Antonio La Marca2, Dilia Giuggioli1 | 1Dipartimento di Scienze Mediche e Chirurgiche, Università di Modena e Reggio Emilia, Italy; 2Dipartimento Materno Infantile. Università di Modena e Reggio Emilia, Italy
46 -
CO:05:1 | Predicting one-year disease activity in systemic lupus erythematosus using machine learning and explainable AI Pier Giacomo Cerasuolo1, Augusta Ortolan1, Livia Lilli2, Laura Antenucci2, Carlotta Maschiocchi2, Jacopo Lenkowicz2, Lucia Lanzo1, Luca Petricca1, Maria Rita Gigante1, Vivianaantonella Pacucci1, Pierluigi Rizzuti1, Rebecca Ventura1, Silvia Piunno1, Cesare Gavotti1, Marco Gorini3, Gabriella Castellino3, Alfredo Cesario2, Stefano Patarnello2, Silvia Laura Bosello1, Maria Antonietta D'Agostino1. | 1UOC di Reumatologia ed Immunologia Clinica, Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma; 2Gemelli Generator, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma; 3AstraZeneca Italy, MIND, Milano, Italy
283 -
PO:31:172 | Age and timing of onset of Raynaud's phenomenon and first non-Raynaud sign/symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the systemic sclerosis progression investigation registry of the Italian Society for Rheumatology Silvia Peretti1, Cosimo Bruni2, Silvia Laura Bosello3, Fabio Cacciapaglia4-5, Corrado Campochiaro6-7, Veronica Codullo8, Lorenzo Dagna6-7, Rossella De Angelis9, Giacomo De Luca6-7, Dilia Giuggioli10, Serena Guiducci1, Florenzo Iannone4, Francesca Ingegnoli11, Valeria Riccieri12, Marco Matucci Cerinic6-7, Clodoveo Ferri10-13, Silvia Bellando Randone1. | 1Division of Rheumatology, Scleroderma Unit, Department of Experimental and Clinical Medicine, University of Florence, AO, Firenze, Italy; 2Division of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; 3Rheumatology Division, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli- IRCCS, Roma, Italy; 4Rheumatology Unit, Department of Precision and Regenerative Medicine-Ionian Area, University of Bari Aldo Moro, Bari, Italy; 5Reumatology Service, Internal Medicine Unit F.Miulli General Hospital, Acquaviva delle Fonti -Department of Medicine a, Bari, Italy; 6Unit of Immunology, Rheumatology, Allergy and Rare Diseases UnIRAR, Inflammation, Fibrosis and Ageing initiative INFL, Milano, Italy; 7Vita-Salute San Raffaele University, Milano, Italy; 8Department of Internal Medicine and Therapeutics, Università di Pavia, Italy; Division of Rheumatology, Fondazione IRCCS, Pavia, Italy; 9Rheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy; 10Rheumatology Unit, School of Medicine, University of Modena and Reggio Emilia, Modena, Italy; 11Division of Clinical Rheumatology, ASST Pini, Dept. of Clinical Sciences and Community Health, Research Center for Adul, Milano, Italy; 12Department of Rheumatology, Sapienza University of Rome, Roma, Italy; 13Rheumatology Clinic Madonna dello Scoglio Crotonei, Crotone, Italy.
283 -
PO:25:071 | Gender differences in Sjögren’s disease: clinical activity, illness perception, and emotional impact Ilenia Fischetti1, Martina Salerno1, Linda Mastromanno1, Angelica Gattamelata1, Martina Villa1, Ludovica Manisera1, Emanuele Grilli1, Luca Quartuccio2, Valeria Manfrè2, Francesco Carubbi3, Evy Di Ruscio3, Fabrizio Conti1, Roberta Priori1|4 | 1UOC di Reumatologia, Dipartimento SCIAC, Sapienza Università di Roma; 2Dipartimento di Medicina, Clinica di Reumatologia, Università degli Studi di Udine; 3UOC Medicina Interna e Nefrologia, Dipartimento MeSVA, Università degli Studi di L'Aquila; 4UniCamillus, San Camillo Università Internazionale di Scienze della Salute di Roma, Italy
183 -
PO:23:048 | Clinical and serological differences of an Italian Sjögren’s disease cohort according to three geographic macro-area localization Maria Letizia Currò1, Roberto Dal Pozzolo2, Giacomo Cafaro2, Valeria Manfrè3, Gaetano La Rocca4, Alessia Alunno5, Francesco Carubbi5, Nicoletta Del Papa6, Viktoriya Pavlych7, Angelica Gattamelata8, Letizia Pia Di Corcia9, Pamela Bernardini10, Luca Quartuccio3, Chiara Baldini4, Paola Cipriani7, Roberta Priori8, Onorina Berardicurti9, Serena Guiducci10, Fabiola Atzeni1, Elena Bartoloni2 | 1Unità di Reumatologia. Università di Messina, Italy; 2SC Reumatologia. Università di Perugia, Italy; 3Unità di Reumatologia. Università di Udine, Italy; 4Unità di Reumatologia. Università di Pisa, Italy; 5Divisione di Medicina Interna e Nefrologia. Università di L'Aquila, Italy; 6Dipartimento di Reumatologia. Università di Milano, Italy; 7Unità di Reumatologia. Università di L'Aquila, Italy; 8UOC Reumatologia. Università Sapienza Roma, Italy; 9Unità di Reumatologia. Università Campus Biomedico Roma, Italy; 10Unità di Reumatologia. Università di Firenze, Italy
46 -
CO:07:5 | Enhanced fibroblast signatures in females with early rheumatoid arthritis highlights a potential basis for poorer treatment outcomes Benedetta Monosi1, James Perera2, Alessandra Nerviani2|3, Maria Sole Chimenti1, Felice Rivellese2|3, Costantino Pitzalis2|3|4. | 1Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; 2Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK; 3Barts Health NHS Trust and Barts Biomedical Research Centre, National Institute for Health and Care Research, London, UK; 4Department of Biomedical Sciences Humanitas University and IRCCS Humanitas Research Hospital, Milano, Italy
3860 -
PO:36:243 | Drug survival, discontinuation reasons and disease activity in patients with Behçet's disease treated with infliximab - a real-life study Antonello Sulis1, Federica Di Cianni1, Maria Laura Manca2, Rosaria Talarico1, Marta Mosca1. | 1Rheumatology Unit of Pisa, University of Pisa, Pisa, Italy, Pisa, Italy; 2Department of Clinical and Experimental Medicine and Department of Mathematics, University of Pisa, Italy, Pisa, Italy.
205 -
CO:12:2 | Circulating cell signatures of disease activity in ANCA-associated vasculitis using automated hematologic profiling analysis with Sysmex XN-9000®: preliminary results from a monocentric cohort Federica Davanzo1, Luca Iorio1, Veronica Davanzo2, Michela Pelloso2, Eleonora Fiorin1, Roberta Prevedello1, Francesca Tosato2, Martina Montagnana3, Roberto Padoan1, Andrea Doria1 | 1Rheumatology Unit, Department of Medicine DIMED, University of Padua Padova, Italy; 2Laboratory Medicine Unit, Biomedical Sciences Department-DSB, University of Padua Padova, Italy; 3Department of Medicine DIMED, University of Padua Padova, Italy
37 -
CO:09:4 | Erosive hand osteoarthritis: the impact of comorbidities in the context of joint disease Sara Bindoli1, Clarissa Benvoluti1, Giacomo Cozzi1, Marta Favero1, Mariagrazia Lorenzin1, Andrea Doria1, Paolo Sfriso1, Roberta Ramonda1. | 1UOC Reumatologia, Dipartimento di Medicina , Università degli studi di Padova, Italy
212 -
PO:01:010 | Survival of second-line treatment with TNF inhibitors vs. IL-23 inhibitors after failure of a first TNF inhibitor: a real-life observational study from the Italian multicenter BIRRA cohort in patients with psoriatic arthritis Francesca Ometto1, Olga Addimanda2, Bernd Raffeiner3, Alberto Lo Gullo4, Elisa Visalli5, Eleonora Celletti6, Antonella Farina7, Maddalena Larosa8, Romina Andracco9, Marino Paroli10, Patrizia Del Medico11, Aldo Biagio Molica Collella12, Federica Lumetti13, Gilda Sandri14, Marta Priora15, Aurora Ianiello16, Elena Bravi17, Alessandra Bezzi18, Palma Scolieri19, Simone Parisi20, Viviana Ravagnani20, Rosetta Vitetta20, Luca Idolazzi20, Riccardo Bixio20, Gianluca Santoboni20, Francesco Girelli20, Alarico Ariani20 | 1Azienda ULSS 6 Euganea, Padova; 2UOC Interaziendale di Medicina Interna ad Indirizzo Reumatologico, AUSL BO - IRCCS AOU Bologna; 3Unità di Reumatologia, Teaching Hospital of the Paracelsius Medical University, Central Hospital of Bolzano (ASAA-SABES) Bolzano; 4UOD Reumatologia, ARNAS Garibaldi Catania; 5UO Reumatologia, Policlinico San Marco Hospital Catania; 6UOS Reumatologia, Ospedale SS. Annunziata, Università G. d'Annunzio, Chieti; 7UOC Medicina Interna- Ambulatorio Reumatologico, Ospedale A. Murri, Fermo; 8S.C. Reumatologia, Dipartimento Specialità Mediche, Ospedale La Colletta-Azienda Sanitaria Locale 3 Genova; 9Ambulatorio Reumatologia, Ospedale di Imperia; 10Sapienza Università Polo Pontino, Latina; 11Ambulatorio di Reumatologia, UO Medicina Interna, Civitanova Marche Hospital, Civitanova (MC); 12UOSD di Reumatologia, Azienda Ospedaliera Papardo Messina; 13Unità di Reumatologia, Azienda USL di Modena e Ospedale Universitario Policlinico di Modena; 14Unità di Reumatologia, Università di Modena e Reggio Emilia Modena; 15Ambulatorio e Day Hospital di Reumatologia, ASL CN1, Mondovì (CN); 16Poliambulatorio specialistico di reumatologia e Day Hospital multidisciplinare di area Medica, ASL Novara; 17UOSD Reumatologia, Ospedale G. Da Saliceto, Piacenza; 18UO Medicina Interna e Reumatologia, SS Reumatologia, ASL Romagna, Rimini; 19UOC Medicina Interna e Reumatologia, Ospedale Nuovo Regina Margherita, Roma; 20Gruppo BIRRA Italy
257 -
PO:14:195 | Real-world effectiveness of anifrolumab in achieving treatment targets and reducing systemic lupus erythematosus disease burden: 6-month interim analysis of the REVEAL study Chiara Cardelli1|2, Chiara Tani1, Luca Moroni3, Filippo Vesentini4, Francesca Bottazzi5, Micaela Fredi6, Ettore Silvagni7, Matteo Piga8, Flavia Riccio9, Fulvia Ceccarelli10, Ginevra De Marchi11, Edoardo Biancalana12, Gianluca Moroncini13, Rita Mulè14, Mariele Gatto15, Laura Coladonato16, Paola Conigliaro17, Maria Gerosa18, Andrea Picchianti Diamanti19, Benedetta Bianchi20, Federica Maiolini20, Michela Gasparotto20, Serena Guiducci20, Maria Ilenia De Andres20, Alberto Lo Gullo20, Silvia Noviello20, On Behalf Of The Reveal Investigators20, Marta Mosca1. | 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa; 2Department of Medical Biotechnologies, University of Siena, Siena; 3Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano; 4Rheumatology Unit, Department of Medicine, University of Padua, Padova; 5Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; 6Rheumatology and Clinical Immunology, Department of Clinical and Experimental Sciences, University of Brescia, Brescia; 7Section of Rheumatology, Department of Medical Sciences, University of Ferrara; AOU Sant'Anna, Ferrara; 8Rheumatology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari; 9Department of Precision Medicine, University of Campania Luigi Vanvitelli, Napoli; 10Rheumatology Unit, Dept. of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Roma; 11Division of Rheumatology, Department of Medicine, Azienda Sanitaria Universitaria del Friuli Centrale, Udine; 12Internal Interdisciplinary Medicine Unit, Department of Experimental and Clinical Medicine, University of Florence, Firenze; 13Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona; 14Azienda Ospedaliero-Universitaria di Bologna, Internal Medicine and Rheumatology, IRCCS S. Orsola Malpighi, Bologna; 15Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin; AO Mauriziano, Torino; 16Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari; 17Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University of Rome, Roma; 18Clinical Rheumatology, ASST Gaetano Pini CTO; Department of Clinical Sciences and Community Health, University of Milano, Milano; 19Department of Clinical and Molecular Medicine, Sapienza University of Rome; AOU Sant'Andrea, Roma, Italy; 20Italian REVEAL Study Group Italy, Italy
255 -
PO:25:083 | Overlap between Sjögren’s syndrome and lichen sclerosus: beyond coincidence? Emanuele Giovanni Grilli1, Ludovica Manisera1, Ilenia Fischetti1, Linda Mastromanno1, Martina Villa1, Angelica Gattamelata1, Fabrizio Conti1, Roberta Priori1|2, Serena Colafrancesco3|4 | 1Dipartimento di Medicina e Chirurgia, Università Milano-Bicocca; 2U.O. Reumatologia, IRCCS Fondazione San Gerardo dei Tintori, Monza; 3U.O. Pneumologia, IRCCS Fondazione San Gerardo dei Tintori, Monza; 4Rheumatology and Clinical Immunology, Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS Humanitas Research Hosp, Rozzano, Milano, Italy
257 -
S05:5 | Romosozumab in Post-Menopausal Women with Multiple Myeloma, a Prospective 12-Month Study Giovanni Adami1, Mariana Diz Lopes1, Camilla Benini1, Davide Gatti1, Ombretta Viapana1, Elena Marchetti2, Martina Tinelli2, Maurizio Rossini1 | 1UOC Reumatologia, Università degli Studi di Verona Verona, Italy; 2UOC Ematologia, Università degli Studi di Verona Verona, Italy
45 -
CO:12:5 | Aortic inflammation and aneurysm risk in giant cell arteritis: a multicenter imaging study Caterina Ricordi1, Chiara Marvisi1, Konstanze V. Guggenberger2, Rudolf A. Werner3, Pamela Mancuso8, Giulia Besutti4, Sebastian E. Serfling5, Roberto Farì4, Matthias Frohlich6, Rexhep Durmo7, Michael Gernert6, Lucia Spaggiari4, Annibale Versari7, Paolo Giorgi Rossi8, Pierpaolo Pattacini4, Marc Schmalzing6, Carlo Salvarani1, Thorsten Bley9, Francesco Muratore1. | 1Rheumatology Unit, AUSL IRCCS di Reggio Emilia and Università di Modena e Reggio Emilia, Italy; 2Department of Diagnostic and Interventional Neuroradiology, University Hospital Wuerzburg, Germany; 3Department of Nuclear Medicine, University of Frankfurt, Germany; 4Department of Radiology, AUSL IRCCS di Reggio Emilia, Italy; 5Department of Nuclear Medicine, University Hospital Wuerzburg, Germany; 6Rheumatology and Clinical Immunology, Department of Internal Medicine II, University Hospital Wuerzburg, Germany; 7Nuclear Medicine Unit, AUSL IRCCS di Reggio Emilia, Italy; 8Epidemiology Unit, AUSL-IRCCS di Reggio Emilia, Italy; 9Department of Diagnostic and Interventional Radiology, University Hospital Wuerzburg, Germany
205 -
PO:07:102 | Predicting success with baricitinib in rheumatoid arthritis: efficacy across ages and serological profiles Daniele Lini1, Matteo Colina2, Romina Andracco3, Francesca Ometto4, Viviana Ravagnani5, Alberto Lo Gullo6, Simone Parisi7, Antonella Farina8, Patrizia Del Medico9, Marino Paroli10, Olga Addimanda1, Alessandra Bezzi11, Federica Lumetti12, Aldo Biagio Molica Colella13, Davide Murgia14, Maddalena Larosa15, Aurora Ianniello16, Elena Bravi17, Marta Priora18, Palma Scolieri19, Alessandro Volpe20. | 1Azienda Unità Sanitaria Locale di Bologna -- Policlinico S.Orsola- Azienda Ospedaliera Universitaria-IRCCS di Bologna, Bologna; 2Rheumatology Service. Department of Medicine and Oncology, Ospedale Santa Maria della Scaletta, Imola; 3Imperia Hospital, Internal Medicine Unit, Rheumatology outpatient clinic, Imperia; 4Azienda ULSS 6 Euganea, Rheumatology Outpatient Clinic, Padova; 5Santa Chiara Hospital APSS Trento, Rheumatology Unit, Trento; 6ARNAS Garibaldi di Catania, Rheumatology Unit, Catania; 7Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Rheumatology Department, Torino; 8Ospedale A. Murri di Fermo, Internal Medicine Unit, Rheumatology outpatient clinic, Fermo; 9Civitanova Marche Hospital, Rheumatology outpatient clinic - Internal Medicine Unit, Civitanova Marche; 10Sapienza University of Rome, Polo Pontino, Department of Clinical, Anesthesiological and Cardiovascular Sciences, Latina; 11ASL Romagna Rimini, Internal Medicine and Rheumatology Unit, Rimini; 12Azienda USL of Modena and University Hospital Policlinico di Modena, Rheumatology Unit, Modena; 13Rheumatology Unit, Azienda Ospedaliera Papardo, Messina; 14ASL VC Ospedale S. Andrea, Unit of Rheumatology, Vercelli; 15Azienda Sanitaria Locale 3 Genova, Division of Rheumatology - Medical Specialties Department, Genova; 16ASL Novara, Rheumatology Outpatient Unit, Novara; 17Ospedale G. Da Saliceto, Rheumatology Unit, Piacenza; 18ASL CN1, Rheumatology Day Hospital and outpatient clinic, Mondovì (CN); 19Nuovo Regina Margherita Hospital, Department of Medical Specialties, Roma; 20IRCCS Sacro Cuore Don Calabria Hospital, Unit of Rheumatology, Negrar, Italy.
195 -
PO:18:276 | Use of anifrolumab in the treatment of difficult-to-treat manifestations in systemic lupus erythematosus Antonella Grimaldi1, Giuseppe Alessandrini2, Laura Quarta1, Maria Rita Ricciardi1, Daniela Costanza1, Clara Minerba1, Eugenio Quarta1 | 1UOC Reumatologia Verona; 2Specialista Dermatologo in Libera Professione, Italy
237 -
PO:24:059 | Sjögren's disease-associated Fibromyalgia: pitfalls in disease assessment using ESSDAI and ESSPRI Lucia Cristiana Colaprico1, Stefano Stano1, Daniele Domanico1, Maria Iacovantuono2, Eduardo Urgesi3, Fabio Cacciapaglia1|4, Maria Giannotta1, Paola Conigliaro2, Vincenzo Venerito1, Maria Sole Chimenti2, Giuseppe Lopalco1, Florenzo Iannone1 | 1Rheumatology Unit - Department of Precision and Regenerative Medicine, Jonian Area DiPReMeJ, University of Bari, Bari, Italy; 2University of Rome Tor Vergata, Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Roma, Italy; 3University Cardiologic Unit - Interdisciplinary Department of Medicine - Policlinico University Hospital, University Bari, Italy; 4Rheumatology Service, Internal Medicine Unit F. Miulli General Hospital, Department of Medicine and Surgery, LUM Casamassima, Italy
73 -
CO:07:6 | Hidden in plain sight: fibromyalgia prevalence and correlates in 3,000 non-clinical Italian subjects Sergio Del Vescovo1, Vincenzo Venerito1, Maria Giannotta1, Maria Grazia Anelli1, Maria Morrone1, Angelo Troiano1, Marco Capodiferro1, Marco Fornaro1, Giuseppe Lopalco1, Florenzo Iannone1. | 1UOC Reumatologia, DiMePre-J, Policlinico di Bari, Italy
229 -
PO:35:227 | Long-term renal and survival outcomes in microscopic polyangiitis: data from an observational monocentric cohort Roberta Prevedello1, Federica Davanzo1, Luca Iorio1, Eleonora Fiorin1, Marta Codirenzi1, Roberto Padoan1, Andrea Doria1. | 1Unità di Reumatologia, Dipartimento di Medicina DIMED, Università degli Studi di Padova, Padova, Italy.
177 -
CO:09:5 | LDL-cholesterol goal attainment with ezetimibe and bempedoic acid in patients with rheumatoid arthritis: a simulation study in the Italian CORDIS cohort Alessandro Giollo1, Kiren Khalid1, Luca Bonanni2, Nicola Ferri3, Gianluca Erre4, Matteo Piga5, Elena Bartoloni6, Andreina Manfredi7, Enno Giulio Favalli8, Maria Sole Chimenti9, Serena Guiducci10, Eleonora Celletti11, Addolorata Corrado12, Simone Parisi20, Ivan Giovannini13, Elisa Gremese14, Garifallia Sakellariou15, Ombretta Viapiana16, Marco Fornaro19, Fabiola Atzeni17, Francesca Romana Spinelli18, Fabio Cacciapaglia19 | 1Università di Padova Padova, Italy; 2UO Medicina Interna ULSS3 Mestre, Italy; 3Università di Padova, Department of Pharmaceutical and Pharmacological Sciences, University of Padova Padova, Italy; 4Università di Sassari Sassari, Italy; 5Università di Cagliari Cagliari, Italy; 6Univeristà degli studi di Perugia Perugia, Italy; 7Università di Modena e Reggio Emilia, UO di Reumatologia Ospedale Policlinico di Modena Reggio Emilia, Italy; 8IRCCS Humanitas Research Hospital, Rozzano Milano, Italy; 9Università Tor Vergata Roma, Italy; 10Università di Firenze Firenze, Italy; 11Ospedale SS. Annunziata Chieti, Italy; 12Università degli studi di Foggia Foggia, Italy; 13Università di Udine, Clinica di Reumatologia Udine, Italy; 14Università degli studi di Milano Milano, Italy; 15Università degli Studi di Pavia Pavia, Italy; 16Università di Verona Verona, Italy; 17Università degli Studi di Messina Messina, Italy; 18Università La Sapienza Roma, Italy; 19Università di Bari, Reumatologia Universitaria Policlinico di Bari Bari, Italy; 20S.C. di Reumatologia A.O.U. Città della Salute e della Scienza di Torino - Ospedale Molinette Torino, Italy
43 -
CO:10:1 | High-grade synovitis and histological pathotype distribution in patients with advanced osteoarthritis undergoing joint replacement: a more inflammatory disease than we thought? Jacopo Ciaffi1, Lorenzo Bianchi1, Luana Mancarella2, Federica Pignatti2, Veronica Brusi2, Lucia Lisi2, Simona Neri2, Elisa Assirelli2, Alberto Righi3, Marco Gambarotti3, Francesco Ursini1. | 1SSD Medicina e Reumatologia, IRCCS Istituto Ortopedico Rizzoli, Alma Mater Studiorum Università di Bologna; 2SSD Medicina e Reumatologia, IRCCS Istituto Ortopedico Rizzoli, Bologna; 3SSD di Anatomia e Istologia Patologica, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
212
